First Header Logo Second Header Logo

Connection

Gustavo Moviglia to Cytotoxicity, Immunologic

Back to Details
This is a "connection" page, showing publications Gustavo Moviglia has written about Cytotoxicity, Immunologic.
Gustavo Moviglia
Connection Strength
0.143
Cytotoxicity, Immunologic
  1. Moviglia GA. Development of tumor B-cell lymphocyte hybridoma (TBH) autovaccination. Results of a phase I-II clinical trial. Transfus Sci. 1996 Dec; 17(4):643-9.
    View in: PubMed
    Score: 0.143
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.